Literature DB >> 6396055

Inactivation of cytochrome P-450 and monoamine oxidase by cyclopropylamines.

R H Tullman, R P Hanzlik.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6396055     DOI: 10.3109/03602538409033560

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  5 in total

1.  An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid.

Authors:  Thomas M Polasek; David J Elliot; Andrew A Somogyi; Elizabeth M J Gillam; Benjamin C Lewis; John O Miners
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

2.  N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.

Authors:  G Klopman; D Fercu; T E Renau; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

3.  Inhibition of cholesterol synthesis by cyclopropylamine derivatives of squalene in human hepatoblastoma cells in culture.

Authors:  W A Van Sickle; M R Angelastro; P Wilson; J R Cooper; A Marquart; M A Flanagan
Journal:  Lipids       Date:  1992-03       Impact factor: 1.880

4.  Synthesis and pharmacological evaluation of 6-naltrexamine analogs for alcohol cessation.

Authors:  Senait Ghirmai; Marc R Azar; John R Cashman
Journal:  Bioorg Med Chem       Date:  2009-08-06       Impact factor: 3.641

5.  In vitro anti-Mycobacterium avium activities of quinolones: predicted active structures and mechanistic considerations.

Authors:  G Klopman; J Y Li; S Wang; A J Pearson; K Chang; M R Jacobs; S Bajaksouzian; J J Ellner
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.